COR · Cencora, Inc. · Webcasts, Transcripts & Audio
$341.25
-7.06 (-2.03%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q4 2026 earnings call transcript
Market Cap
$65.12B
Shares
190.83M
Volume · Nov 19
1.5M
Avg daily vol (3M)
1.28M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Cencora, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Cencora, Inc. (COR), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q4
2026-11-04
Cencora, Inc. (COR) Q4 2026 Earnings Call Transcript
Confident tone
MSO acquisitions and physician expansion
Fiscal 2027 consolidated guidance
Specialty growth platform
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Conference
Investor event
2026-09-15
Cencora, Inc. (COR) September 15, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-15
Cencora, Inc. (COR) September 15, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-08
Cencora, Inc. (COR) September 8, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-08-05
Cencora, Inc. (COR) Q3 2026 Earnings Call Transcript
Confident tone
Specialty pharmaceutical platform and growth
Talent and leadership transitions
International / European distribution strength
Revenue
$84.75B
▲ 5.1% YoY Diluted EPS
$3.94
▲ 11.9% YoY Gross margin
4.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-05-13
Cencora, Inc. (COR) May 13, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-05-06
Cencora, Inc. (COR) Q2 2026 Earnings Call Transcript
Positive tone
Specialty pharmaceuticals and MSO platform
EPS growth and fiscal 2026 guidance
Capital deployment and share repurchases
Revenue
$78.36B
▲ 3.8% YoY Diluted EPS
$8.40
▲ 128.3% YoY Gross margin
4.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-03-10
Cencora, Inc. (COR) March 10, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-02-04
Cencora, Inc. (COR) Q1 2026 Earnings Call Transcript
Confident tone
MSO expansion and acquisitions
Guidance raise
Specialty pharmaceuticals leadership
Revenue
$85.93B
▲ 5.5% YoY Diluted EPS
$2.87
▲ 14.8% YoY Gross margin
3.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2025-11-05
Cencora, Inc. (COR) Q4 2025 Earnings Call Transcript
Confident tone
Strategic portfolio review / divestitures
Capital deployment
Specialty growth and positioning
Revenue
$83.73B*
▲ 5.9% YoY Gross margin
3.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-08-06
Cencora, Inc. (COR) Q3 2025 Earnings Call Transcript
Positive tone
Specialty Pharmaceuticals and RCA
GLP-1 Profitability Outlook
Pharmaceutical Distribution and DSCSA
Revenue
$80.66B
▲ 8.7% YoY Diluted EPS
$3.52
▲ 45.5% YoY Gross margin
3.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-05-07
Cencora, Inc. (COR) Q2 2025 Earnings Call Transcript
Confident tone
Specialty Pharmaceuticals & Global Leadership
MSOs / M&A (One Oncology, RCA)
Guidance Raise & EPS Growth
Revenue
$75.45B
▲ 10.3% YoY Diluted EPS
$3.68
▲ 76.1% YoY Gross margin
4.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-02-05
Cencora, Inc. (COR) Q1 2025 Earnings Call Transcript
Confident tone
Specialty growth and acquisitions
COVID vaccine headwind
World Courier / clinical trial softness
Revenue
$81.49B
▲ 12.8% YoY Diluted EPS
$2.50
▼ 16.1% YoY Gross margin
3.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2024-11-06
Cencora, Inc. (COR) Q4 2024 Earnings Call Transcript
Positive tone
RCA Acquisition and Specialty Expansion
CEO Transition
IRA and Regulatory Policy
Revenue
$79.05B*
▲ 14.7% YoY Gross margin
3.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-07-31
Cencora, Inc. (COR) Q3 2024 Earnings Call Transcript
Confident tone
Quarterly financial performance and raised outlook
Good Neighbor Pharmacy and ThoughtSpot
Pharmaceutical-centric strategy and integrated solutions
Revenue
$74.24B
▲ 10.9% YoY Diluted EPS
$2.42
▲ 3% YoY Gross margin
3.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-05-01
Cencora, Inc. (COR) Q2 2024 Earnings Call Transcript
Confident tone
Financial results and EPS growth
CEO succession
Pharmaceutical manufacturers and commercialization services
Revenue
$68.41B
▲ 7.8% YoY Diluted EPS
$2.09
▼ 1.9% YoY Gross margin
3.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-01-31
Cencora, Inc. (COR) Q1 2024 Earnings Call Transcript
Confident tone
Full-Year Guidance Raise
GLP-1 Demand and Growth
International Segment and Egypt Headwind
Revenue
$72.25B
▲ 15% YoY Diluted EPS
$2.98
▲ 27.9% YoY Gross margin
3.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-11-02
Cencora, Inc. (COR) Q4 2023 Earnings Call Transcript
Revenue
$68.92B*
▲ 12.7% YoY Gross margin
3.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-08-02
Cencora, Inc. (COR) Q3 2023 Earnings Call Transcript
Revenue
$66.95B
▲ 11.5% YoY Diluted EPS
$2.35
▲ 22.4% YoY Gross margin
3.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-05-02
Cencora, Inc. (COR) Q2 2023 Earnings Call Transcript
Revenue
$63.46B
▲ 9.9% YoY Diluted EPS
$2.13
▼ 17.8% YoY Gross margin
3.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-02-01
Cencora, Inc. (COR) Q1 2023 Earnings Call Transcript
Revenue
$62.85B
▲ 5.4% YoY Diluted EPS
$2.33
▲ 9.4% YoY Gross margin
3.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-11-03
Cencora, Inc. (COR) Q4 2022 Earnings Call Transcript
Revenue
$61.17B*
▲ 3.8% YoY Gross margin
3.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-08-03
Cencora, Inc. (COR) Q3 2022 Earnings Call Transcript
Revenue
$60.06B
▲ 12.5% YoY Diluted EPS
$1.92
▲ 37.1% YoY Gross margin
3.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-05-04
Cencora, Inc. (COR) Q2 2022 Earnings Call Transcript
Revenue
$57.72B
▲ 17.4% YoY Diluted EPS
$2.59
▲ 23.3% YoY Gross margin
3.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-02-02
Cencora, Inc. (COR) Q1 2022 Earnings Call Transcript
Revenue
$59.63B
▲ 13.5% YoY Diluted EPS
$2.13
▲ 17.7% YoY Gross margin
3.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2021-11-04
Cencora, Inc. (COR) Q4 2021 Earnings Call Transcript
Revenue
$58.91B*
▲ 19.6% YoY Gross margin
3.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-08-04
Cencora, Inc. (COR) Q3 2021 Earnings Call Transcript
Revenue
$53.41B
▲ 17.7% YoY Diluted EPS
$1.40
▼ 0.7% YoY Gross margin
3.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-05-05
Cencora, Inc. (COR) Q2 2021 Earnings Call Transcript
Revenue
$49.15B
▲ 3.7% YoY Diluted EPS
$2.10
▼ 54.7% YoY Gross margin
3.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-02-04
Cencora, Inc. (COR) Q1 2021 Earnings Call Transcript
Revenue
$52.52B
▲ 9.7% YoY Diluted EPS
$1.81
▲ 101.1% YoY Gross margin
2.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2020-11-05
Cencora, Inc. (COR) Q4 2020 Earnings Call Transcript
Revenue
$49.24B
▲ 7.9% YoY Diluted EPS
$-23.74
▼ 3868.3% YoY Gross margin
2.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-08-05
Cencora, Inc. (COR) Q3 2020 Earnings Call Transcript
Revenue
$45.37B
▲ 0.3% YoY Diluted EPS
$1.41
▼ 1.4% YoY Gross margin
2.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-05-07
Cencora, Inc. (COR) Q2 2020 Earnings Call Transcript
Revenue
$47.42B
▲ 9.5% YoY Diluted EPS
$4.64
▲ 3469.2% YoY Gross margin
2.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-01-30
Cencora, Inc. (COR) Q1 2020 Earnings Call Transcript
Revenue
$47.86B
▲ 5.4% YoY Diluted EPS
$0.90
▼ 51.1% YoY Gross margin
2.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–33 of 33 webcasts
Key facts
CIK
1140859
CUSIP
03073E105
13F (30d)
1274 filings
1159 filers
Visit website
Investor relations